Yasmin And Yaz MDL (Multidistrict Litigation) Assigned To Judge David R. Herndon, Southern District of Illinois
MDL No. 2100: Consolidation Of All Yaz, Yasmin, And Ocella Lawsuits Alleging Personal Injury Or Wrongful Death That Are Filed In Federal Court System
On October 1, 2009 the United States Judicial Panel on Multidistrict Litigation (JPML) issued a Transfer Order which creates MDL No. 2100 -- IN RE: Yasmin and Yaz (Drospirenone) Marketing and Sales Practices and Products Liability Litigation.
By operation of this JPML Transfer Order, all Yaz, Yasmin, and Ocella personal injury and wrongful death cases filed in the federal court system will be consolidated into a Multidistrict Litigation, or MDL, with U.S. District Court Judge David R. Herndon presiding over these Yaz, Yasmin, and Ocella cases for "coordinated or consolidated pretrial proceedings".
From the October 2009 JPML Transfer Order for MDL No. 2100:
On the basis of the papers filed and hearing session held, we find that these 32 actions involve common questions of fact, and that centralization under Section 1407 in the Southern District of Illinois will serve the convenience of the parties and witnesses and promote the just and efficient conduct of this litigation. All actions share factual questions relating to at least one of the drospirenone-containing oral contraceptives Yaz and Yasmin, which are manufactured by Bayer. Plaintiffs in the products liability actions challenge the safety of those oral contraceptives and bring claims for personal injuries or wrongful death stemming from use of the drugs....
Yaz, Yasmin and Ocella, as well as Gianvi, Zarah, Loryna, Syeda, Beyaz, and Safyral, have been associated with various serious side effects, including:
- Blood Clots
- Deep Vein Thrombosis (DVT)
- Pulmonary Embolism (PE)
- Cerebrovascular Accidents
- Heart Attack
- Myocardial Infarction
- Gallbladder Disease / Injury
- Gallbladder Removal (cholecystectomy)
In essence, the theory of liability being asserted in personal injury and wrongful death lawsuits which have been filed on behalf of women who used Yaz, Yasmin, Ocella, Gianvi, Zarah, Loryna, Syeda, Beyaz, or Safyral and suffered one of these serious side effects is that the current warnings about those side effects are either insufficient or not shown at all on the package insert, or label, for these birth control pills containing drospirenone (DRSP).
Go to Free Case Evaluation form >>
Read more on our Drospirenone (DRSP) Birth Control Pills Information Page >>